Scientists say they have identified a mutated autoantibody gene as the mechanism behind rare but serious abnormal blood ...

Rare but dangerous blood clotting associated with that vaccine as well as AstraZeneca’s had a genetic cause, according to a new paper.

Researchers identify genetic mutation in small group of people who developed the serious disorder after receiving the AstraZeneca or Johnson & Johnson vaccine.

Rare but deadly blood clots tied to J&J and AstraZeneca's vaccines were caused by an autoimmune reaction that some people are predisposed to, researchers found.

A vaccine with University of Washington roots that fights a suite of coronaviruses including COVID-19 and related, deadly ...

Moderna (NASDAQ: MRNA) reported fourth-quarter results Friday morning that beat Wall Street’s muted expectations, delivering ...

The clots occurred in two to three out of every 100,000 people who received the vaccine.

SYDNEY, Sept 6 (Reuters) - Australia will receive the first doses of an AstraZeneca (AZN.L), opens new tab and Oxford University COVID-19 vaccine in January 2021 if trials prove successful, after ...

A global research collaboration of scientists from McMaster University (Canada), Flinders University (Australia) and Universitätsmedizin Greifswald (Germany) uncovered why a small number of people ...

NEW YORK (Reuters) -Americans headed to pharmacies for COVID-19 vaccines are running into roadblocks and confusion due to new U.S. guidance that abandoned broad support for the shots, contributing to ...

MELBOURNE, Jan 27 (Reuters) - Australia's cricket board said on Wednesday it had asked authorities about the timeline for COVID-19 vaccinations as part of its planning for the South Africa tour, amid ...